CME

CME


Therapy Gaps: Identifying New Targets in the Management of NSCLC

May 20, 2021

Host: Paul Paik, MD

Guest: Viola Zhu, MD

Dysregulation of MET signaling has been widely described in oncogenic processes. While all 3 types of MET dysregulation (amplification, overexpression, and gene mutations) have been documented in non-small c